Cigna CI Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $277.89B+1.1% | $274.9B+2.5% | $268.08B+2.3% | $262.02B+2.6% | $255.37B+3.3% | ||
| $220.69B+2.7% | $214.99B+4.3% | $206.22B+4.0% | $198.25B+4.6% | $189.48B+3.8% | ||
| $57.2B-4.5% | $59.91B-3.2% | $61.86B-3.0% | $63.77B-3.2% | $65.89B+2.0% | ||
| 20.6%-1.2pp | 21.8%-1.3pp | 23.1%-1.3pp | 24.3%-1.5pp | 25.8%-0.3pp | ||
| $14.13B-3.4% | $14.62B-1.7% | $14.87B-1.5% | $15.1B-1.6% | $15.35B+3.4% | ||
| $9.59B+4.2% | $9.2B+1.9% | $9.03B0.0% | $9.03B-1.2% | $9.13B-3.0% | ||
| 3.4%+0.1pp | 3.3%0.0pp | 3.4%-0.1pp | 3.4%-0.1pp | 3.6%-0.2pp | ||
| $8.4B+8.0% | $7.78B-2.4% | $7.97B+16.1% | $6.87B+0.5% | $6.84B+29.8% | ||
| $1.66B+11.4% | $1.49B+4.9% | $1.42B-3.1% | $1.47B+2.0% | $1.44B-3.5% | ||
| $6.2B+5.6% | $5.87B-4.1% | $6.12B+23.1% | $4.97B+0.1% | $4.97B+44.7% | ||
| 2.2%+0.1pp | 2.1%-0.1pp | 2.3%+0.4pp | 1.9%0.0pp | 1.9%+0.6pp | ||
| $23.61+6.4% | $22.20-1.8% | $22.61+23.8% | $18.26+1.4% | $18.00+47.8% | ||
| $12.34B+3.0% | $11.98B+2.1% | $11.73B+0.4% | $11.68B-1.4% | $11.84B-2.9% | ||
| 4.4%+0.1pp | 4.4%0.0pp | 4.4%-0.1pp | 4.5%-0.2pp | 4.6%-0.3pp | ||
| $9.59B+4.2% | $9.2B+1.9% | $9.03B0.0% | $9.03B-1.2% | $9.13B-3.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Cigna's revenue?
- Cigna (CI) generated $277.89B in revenue over the trailing twelve months, up 8.8% year over year.
- Is Cigna profitable?
- Cigna reported $6.2B in net income over the trailing twelve months, a 2.2% net margin.
- What are Cigna's profit margins?
- Gross margin is 20.6% and operating margin is 3.4%, with a 2.2% net margin.
- What is Cigna's earnings per share?
- Cigna's diluted EPS over the trailing twelve months is $23.61.
- Where does Cigna's income statement data come from?
- Every line is extracted from Cigna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
